PTPN18 WT decreased ETS1 stability and inhibited breast cancer metastasis, but two cytoplasmic PTPN18 mutants, mC-NLS and mPY-NLS, stabilized ETS1 and restored the metastatic ability by spatiotemporal regulation. Here, PTPN18 is linked to breast carcinoma.